Skip to main content
Premium Trial:

Request an Annual Quote

Fitch Ups Beckman's Credit Rating After Biosite Forfeit Showed 'Financial Discipline'

NEW YORK (GenomeWeb News) — Credit-rating firm Fitch Ratings on Thursday raised its outlook for Beckman Coulter to “stable” from “negative,” largely in response to Beckman’s decision to step away from a bidding war with Inverness Medical Innovations over the firms' intent to acquire Biosite.
 
Fitch had lowered Beckman's credit rating in late March, just after Beckman disclosed its intent to buy the diagnostics company for $85 a share.
 
But Fitch’s analysts said Beckman showed “financial discipline by walking away from the transaction” as the price rose with Inverness’ rival offers.   
 
Fitch also said that it is “concerned” with the company’s recent shareholder payout dividend and stock buybacks.
The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.